炎症因素对不稳定性胸痛风险的影响,从基因层面来看
Jie Lou1, QianZhen Huang1, Runfeng Zhan2,3
1of Clinical Laboratory, Taicang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, No.140 renminnan road, Taicang, Jiangsu Province, China.
Scientific reports
|February 3, 2026
概括
炎症性细胞因子基因的遗传变异与中国人口的不稳定性心肌痛 (UA) 风险有关. 在IL-1β和TNF-α基因中的特定多态性与增加UA易受性和更高的炎症反应有关.
科学领域:
- 遗传学和分子生物学
- 心血管疾病研究研究
- 免疫学 免疫学 免疫学
背景情况:
- 炎症及其遗传调节在不稳定的心痛 (UA) 中至关重要,这是冠状动脉疾病 (CAD) 的表现.
- 影响UA细胞因子产生和炎症反应的遗传因素,特别是在中国人群中,需要进一步阐明.
研究的目的:
- 调查炎症性细胞因子基因多态,血清细胞因子水平和中国队列中不稳定性心痛风险之间的关联.
- 为了确定冠状动脉不稳定的潜在遗传生物标志物.
主要方法:
- 一项基于医院的病例控制研究,涉及160名UA患者和280名健康对照.
- 使用ELISA对血清细胞因子 (IL-1β,IL-6,IL-10,IL-17,IFN-γ,TNF-α) 的量化.
- 使用聚合酶链反应-限制片段长度多态 (PCR-RFLP) 和通过多变量逻辑回归进行关联分析,对13种细胞因子基因位点的基因定型.
主要成果:
- 与对照组相比,UA患者的所有测量细胞因子的血清水平显著升高 (p < 0.01),IL-10显示增加了3.2倍.
- 七个细胞因子基因位点的多态性,包括IL-1β-511 C/T和TNF-α-308 G/A,与UA敏感性显著相关 (p <0.05).
- 对IL-1β-511 C/T (AUC=0.87) 和TNF-α-308 G/A (AUC=0.84) 多态形态的ROC分析显示出强大的区分能力,灵敏度和特异性>80%.
结论:
- 特定的炎症性细胞因子基因多态,特别是IL-1β-511 C/T和TNF-α-308 G/A,与中国人群中UA风险增加和炎症反应加剧有关.
- 这些多态可能作为冠状动脉不稳定的潜在遗传生物标志物,需要进一步验证临床应用.
相关概念视频
Factors Affecting the Risk of Infection
13.5K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.5K
Angina I: Introduction
536
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
536
Angina II: Classification
396
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
396
Angina IV: Management
291
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
291
Angina V: Nursing Management
351
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
351
Transcription Factors
82.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.8K


